Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy
NCT03182153 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 83
Last updated 2018-06-27
Summary
Eligible subjects will wear 4 consecutive external monitoring devices for a total of 28 days of monitoring.
Conditions
Interventions
- DEVICE
-
Extended Cardiac Monitoring
Extended External Cardiac Monitoring
Sponsors & Collaborators
-
Atlantic Health System
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2018-12-28
- Completion
- 2018-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Dynamic EchoCardiographic Optimisation REsponse Study
NCT05473481 ·Status: UNKNOWN
-
Efficacy, Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy
NCT03012490 ·Status: COMPLETED ·Phase: NA
-
Cardiac Resynchronization in the Elderly
NCT03031847 ·Status: COMPLETED ·Phase: NA
-
Quadripolar Pacing Post Approval Study
NCT01555619 ·Status: COMPLETED
-
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
NCT00180531 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure
NCT02145351 ·Status: COMPLETED ·Phase: NA
-
External Sensors for remoTe MoniToring of Heart Failure Patients With Implantable Defibrillators
NCT02147340 ·Status: UNKNOWN
-
Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes
NCT05505136 ·Status: COMPLETED
-
Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement
NCT01711281 ·Status: COMPLETED ·Phase: PHASE4
-
Monitor Patients With Acute Heart Failure
NCT00919828 ·Status: COMPLETED
-
INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients With Remotely Monitored Implanted Cardioverter Defibrillators (ICD) SysTems
NCT01200381 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
NCT00115843 ·Status: WITHDRAWN ·Phase: NA
-
Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
NCT06352060 ·Status: COMPLETED
-
Heart Failure Study of Multi-site Pacing Effects on Ventriculoarterial Coupling
NCT03189368 ·Status: COMPLETED
-
Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy
NCT04157205 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hemodynamic-GUIDEd Management of Heart Failure
NCT03387813 ·Status: COMPLETED ·Phase: NA
-
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
NCT03579641 ·Status: COMPLETED
-
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
NCT00538356 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of MultiPoint Pacing Technology in CRT Patients With Reduced RV-to-LV Delay
NCT02713308 ·Status: UNKNOWN
-
CardioMEMS HF System Real-World Evidence Post-Approval Study
NCT06306573 ·Status: ENROLLING_BY_INVITATION
-
Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study
NCT00500838 ·Status: COMPLETED ·Phase: NA
-
BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction
NCT02341534 ·Status: COMPLETED ·Phase: NA
-
Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
NCT01121107 ·Status: COMPLETED ·Phase: NA
-
Cardiac Resynchronization Therapy (CRT)-Narrow-dp/Dt-Study
NCT00821938 ·Status: COMPLETED ·Phase: PHASE4
-
CCM in Heart Failure With Preserved Ejection Fraction
NCT03240237 ·Status: COMPLETED ·Phase: NA